| Background: | SLC6A13, also known as GAT2, is a member of the Na+ - and Cl- -dependent neurotransmitter transporter family, and is preferentially expressed in the brain, retina, liver, and kidney. By using the Xenopus oocyte expression system, the function of SLC6A13 has been revealed to be the transport of the neurotransmitter GABA and ï¢-alanine. |
| Clonality: | Polyclonal |
| Formulation: | In PBS/50% glycerol, pH 7.2 |
| Gene ID Human: | 6540 |
| Gene ID Mouse: | 14412 |
| Host Species: | Rabbit |
| Immunogen: | Human SLC6A13-derived synthetic peptide |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 50 µL |
| Species Reactivities: | Human |
| Status: | RUO |
| Storage: | -20℃ |
| Target: | SLC6A13 |
Applications: FCM, IC, IH, WB
| FCM: | 1:1000 |
| ICC: | 1:1000 |
| IHC: | 1:5000 (Heat treatment is necessary for paraffin e |
| WB: | 1:1000 |
There are no references for Anti-SLC6A13 (GAT2) (Human) pAb at this time.